rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pfizer, Inc.

PFE · NYSE

Health CarePharmaceuticalsLeading

PFE stood above a rising 150-day average in 35 of the last 52 weekly readings, including each of the last 10 weeks. It is 13.0% above that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
10 in a row
Industry in uptrend
32% -10 in 4 wk
Insider buys, 12 months
$5.9M
Insider sales, 12 months
$269K
Officials’ trades on record
329

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.

21 Apr – 20 Oct
24%34%45%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$5.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

329 disclosed lines: House 164, Senate 142, executive 23; 85 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k21 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$100k–$250k31 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k23 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k12 Jun 2026filed 22 Aug 2026
Tommy Tuberville Senate: U.S. Senate eFDSenatorsoldjoint$15k–$50k8 Jun 2026filed 16 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k18 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k11 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 Apr 2026filed 1 Jul 2026

Insiders

Buy orders, 12 months3
Sale orders, 12 months2
Buyers · sellers3 · 1
WhoDidSharesTraded
Albert BourlaChairman & CEObought38,000at $26.3412 Aug 2026filed 12 Aug 2026
Mortimer J. BuckleyDirectorbought37,632at $25.525 Aug 2026filed 5 Aug 2026
Ronald E. BlaylockDirectorbought39,231at $25.465 Aug 2026filed 5 Aug 2026
Jennifer B. DamicoSVP & Controllersold3,278at $25.405 Aug 2026filed 6 Aug 2026
Jennifer B. DamicoSVP & Controllersold2,000at $25.709 Jun 2026filed 10 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

News

Everyone who traded it

Albert Bourla Company insiderChairman & CEO · last 15 Oct 20261 · 2
Cyrus Taraporevala Company insiderDirector · last 25 Sep 20260 · 0
James C. Smith Company insiderDirector · last 25 Sep 20261 · 1
James Quincey Company insiderDirector · last 25 Sep 20260 · 0
Joseph Echevarria Company insiderDirector · last 25 Sep 20260 · 0
Mortimer J. Buckley Company insiderDirector · last 25 Sep 20261 · 0
Shantanu Narayen Company insiderDirector · last 25 Sep 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 21 Aug 202610 · 5
Jennifer B. Damico Company insiderSVP & Controller · last 5 Aug 20260 · 12
Ronald E. Blaylock Company insiderDirector · last 5 Aug 20263 · 0
Tommy Tuberville SenateSenator · last 8 Jun 20264 · 3
Dan R. Littman Company insiderDirector · last 23 Apr 20260 · 0

160 people in all.

Same industry

ABBV AbbVieLeading+22%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202574.3%
Free cash flow marginFY 2025 · to 31 Dec 202514.5%
Cash conversionFY 2025 · to 31 Dec 2025151%
Debt to equityFY 2025 · to 31 Dec 20250.75×
Share count trendFY 2025 · to 19 Feb 2026-0.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.1B
Free cash flowFY 2025 · to 31 Dec 2025$9.1B

Analyst forecasts

No analyst forecasts yet.